NeoPharm Co Ltd
KOSDAQ:092730
Wall Street
Price Targets
Price Targets Summary
NeoPharm Co Ltd
According to Wall Street analysts, the average 1-year price target for NeoPharm Co Ltd is 36 000 KRW .
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NeoPharm Co Ltd's stock price target?
Price Target
36 000
KRW
According to Wall Street analysts, the average 1-year price target for NeoPharm Co Ltd is 36 000 KRW .
What is NeoPharm Co Ltd's Revenue forecast?
Projected CAGR
19%
For the last 8 years the compound annual growth rate for NeoPharm Co Ltd's revenue is 13%. The projected CAGR for the next 2 years is 19%.
What is NeoPharm Co Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for NeoPharm Co Ltd's operating income is 19%. The projected CAGR for the next 2 years is 16%.
What is NeoPharm Co Ltd's Net Income forecast?
Projected CAGR
6%
For the last 8 years the compound annual growth rate for NeoPharm Co Ltd's net income is 27%. The projected CAGR for the next 2 years is 6%.